Adial Pharmaceuticals, Inc. Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net
Adial Pharmaceuticals, Inc. (ADIL) had Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net of $1.73 million as of 2024-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Balance Sheet › Assets › Assets, Current › Disposal Group, Including Discontinued Operation, Assets, Current
us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet · last filed 2025-03-04
- 2024-12-31: Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $1.73M.
- 2023-12-31: Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $1.73M.
| Period end | Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net |
|---|---|
| 2024-12-31 | $1.73M 10-K · filed 2025-03-04 |
| 2023-12-31 | $1.73M 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |